The 5th 5-year Business Plan (FY2021 - FY2025)

Target and the latest Estimate for FY2025 KPI

	At the time of planning 5YBP	As of Apr. 2024	As of Apr. 2025
Revenue	1.6 Tr JPY	2.1 Tr JPY	2.0 Tr JPY
Revenue in Oncology	> 600 Bn JPY	> 1.0 Tr JPY	900 Br JPY
Core Operating Profit ratio before R&D expense	40%	40％	40％
ROE	> 16%	> 16％	> 16％
DOE*	> 8％	> 8.5％	> 8.5%
Currency exchange rate assumptions	1USD＝105JPY, 1EUR＝120JPY	1USD=145JPY, 1EUR＝155JPY	1USD=140JPY, 1EUR＝160JPY

• The 5th 5-year Business Plan Update (Presentation of Financial Results FY2024 Q4 on April 25th, 2025)
• <Original Presentation Material as of April 21st, 2021>
• <Streaming as of April 21st, 2021>

The 4th 5-year Business Plan Overview and Progress

(The following is an excerpt from the Value Report 2019.)

• <PDF> (0.51MB)
• <Ebook>

Revised Target for the 4th 5-Year Business Plan (October 31, 2018)

• <PDF> (0.75MB)